These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 23517805)

  • 21. Stereotactic ablative radiation therapy for centrally located recurrences of non-small cell lung cancer: in regard to Chang et al.
    Oskan F
    Int J Radiat Oncol Biol Phys; 2014 Aug; 89(5):1141-1142. PubMed ID: 25035222
    [No Abstract]   [Full Text] [Related]  

  • 22. A dose-volume analysis of radiation pneumonitis in non-small cell lung cancer patients treated with stereotactic body radiation therapy.
    Barriger RB; Forquer JA; Brabham JG; Andolino DL; Shapiro RH; Henderson MA; Johnstone PA; Fakiris AJ
    Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):457-62. PubMed ID: 21035956
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Management of Stage I Lung Cancer with Stereotactic Ablative Radiation Therapy.
    Dan T; Williams NL
    Surg Oncol Clin N Am; 2017 Jul; 26(3):393-403. PubMed ID: 28576179
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dose and Fractionation in Stereotactic Body Radiation Therapy for Stage I Non-Small Cell Lung Cancer: Lessons Learned and Where Do We Go Next?
    Guckenberger M
    Int J Radiat Oncol Biol Phys; 2015 Nov; 93(4):765-8. PubMed ID: 26530744
    [No Abstract]   [Full Text] [Related]  

  • 25. Radiation-induced rib fractures after hypofractionated stereotactic body radiation therapy of non-small cell lung cancer: a dose- and volume-response analysis.
    Pettersson N; Nyman J; Johansson KA
    Radiother Oncol; 2009 Jun; 91(3):360-8. PubMed ID: 19410314
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Can stereotactic fractionated radiation therapy become the standard of care for early stage non-small cell lung carcinoma.
    Nguyen NP; Garland L; Welsh J; Hamilton R; Cohen D; Vinh-Hung V
    Cancer Treat Rev; 2008 Dec; 34(8):719-27. PubMed ID: 18657910
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Stereotactic body radiation therapy in stage I inoperable lung cancer: from palliative to curative options.
    Boujelbene N; Elloumi F; Kamel ME; Abeidi H; Matzinger O; Mirimanoff RO; Khanfir K
    Swiss Med Wkly; 2013; 143():w13780. PubMed ID: 23740331
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Stereotactic radiosurgery for lung tumors.
    Whyte RI
    Semin Thorac Cardiovasc Surg; 2010; 22(1):59-66. PubMed ID: 20813318
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Focal, high dose, and fractionated modified stereotactic radiation therapy for lung carcinoma patients: a preliminary experience.
    Uematsu M; Shioda A; Tahara K; Fukui T; Yamamoto F; Tsumatori G; Ozeki Y; Aoki T; Watanabe M; Kusano S
    Cancer; 1998 Mar; 82(6):1062-70. PubMed ID: 9506350
    [TBL] [Abstract][Full Text] [Related]  

  • 30. SABR versus conventional fractionation regimens in NSCLC.
    Joseph N; Choudhury A
    Lancet Oncol; 2019 May; 20(5):e231. PubMed ID: 31044708
    [No Abstract]   [Full Text] [Related]  

  • 31. SABR versus conventional fractionation regimens in NSCLC.
    Addeo A; Buffoni L
    Lancet Oncol; 2019 May; 20(5):e230. PubMed ID: 31044707
    [No Abstract]   [Full Text] [Related]  

  • 32. The North American experience with stereotactic body radiation therapy in non-small cell lung cancer.
    Timmerman RD; Park C; Kavanagh BD
    J Thorac Oncol; 2007 Jul; 2(7 Suppl 3):S101-12. PubMed ID: 17603304
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment Outcomes in Stage I Lung Cancer: A Comparison of Surgery and Stereotactic Body Radiation Therapy.
    Poullis M
    J Thorac Oncol; 2016 May; 11(5):e64-e65. PubMed ID: 27131296
    [No Abstract]   [Full Text] [Related]  

  • 34. Clinical and dosimetric predictors of radiation pneumonitis in a large series of patients treated with stereotactic body radiation therapy to the lung.
    Baker R; Han G; Sarangkasiri S; DeMarco M; Turke C; Stevens CW; Dilling TJ
    Int J Radiat Oncol Biol Phys; 2013 Jan; 85(1):190-5. PubMed ID: 22929858
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic factors in stereotactic body radiotherapy for non-small-cell lung cancer.
    Matsuo Y; Shibuya K; Nagata Y; Takayama K; Norihisa Y; Mizowaki T; Narabayashi M; Sakanaka K; Hiraoka M
    Int J Radiat Oncol Biol Phys; 2011 Mar; 79(4):1104-11. PubMed ID: 20472343
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dose-volume parameters predict for the development of chest wall pain after stereotactic body radiation for lung cancer.
    Mutter RW; Liu F; Abreu A; Yorke E; Jackson A; Rosenzweig KE
    Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):1783-90. PubMed ID: 21868173
    [TBL] [Abstract][Full Text] [Related]  

  • 37. SBRT effective for inoperable early-stage lung cancer.
    Cancer Discov; 2014 Dec; 4(12):OF2. PubMed ID: 25477119
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Stereotactic radiotherapy is established treatment in localized non-small cell lung cancer].
    Sailas L; Virsunen H
    Duodecim; 2016; 132(6):571-5. PubMed ID: 27132296
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In Response to Treatment Outcomes in Stage I Lung Cancer: A Comparison of Surgery and Stereotactic Body Radiation Therapy.
    Puri V; Robinson CG
    J Thorac Oncol; 2016 May; 11(5):e65-e66. PubMed ID: 27131297
    [No Abstract]   [Full Text] [Related]  

  • 40. Stereotactic body radiation therapy of lung tumors: preliminary experience using normal tissue complication probability-based dose limits.
    Song DY; Benedict SH; Cardinale RM; Chung TD; Chang MG; Schmidt-Ullrich RK
    Am J Clin Oncol; 2005 Dec; 28(6):591-6. PubMed ID: 16317270
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.